Orthofix Medical Inc. (NASDAQ:OFIX) headquartered in Lewisville, will host a conference call for the investment community to discuss the 3Q20 earnings result on 5th November 2020 at 8:30 AM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.orthofix.com
Earnings Expectation
Orthofix Medical Inc. is reporting third quarter earnings results on Thursday 5th November 2020, before market open.
The consensus estimates from Thomson Reuters are loss of $ 0.36 per share from $ 86.58 million in revenue. For the full year, analysts predict revenues of $ 374.30 million, while looking forward to loss of $ 0.38 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 467.00 million ~ $ 477.00 million, where as bottomline are predicted in a range of $ 1.00 ~ $ 1.10 per share
Click Here For More Historical Outlooks Of Orthofix Medical Inc.
Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. The Bone Growth Therapies segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spinal appendicular fractures.
